Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy
European Journal of Medicinal Chemistry - France
doi 10.1016/j.ejmech.2013.01.023
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2013
Authors
Publisher
Elsevier BV